Endo-lysosomal Aβ concentration and pH trigger formation of Aβ oligomers that potently induce Tau missorting

Marie P Schützmann1, Filip Hasecke1, Sarah Bachmann2

  • 1Institut für Physikalische Biologie, Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Germany.

Nature Communications
|July 31, 2021
PubMed

Insights

Alzheimer's disease peptide (Aβ) oligomers form faster in acidic neuron compartments, driving Tau pathology. This suggests endosomes are key sites for toxic Aβ oligomer assembly.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Cell Biology

Background:

  • Amyloid-β oligomers (AβOs) are potent drivers of Alzheimer's disease pathology.
  • AβOs are more toxic than amyloid fibrils, causing synaptic dysfunction and Tau pathology.
  • Aβ accumulates in acidic endo-lysosomal vesicles within neurons.

Purpose of the Study:

  • To investigate the effect of pH on AβO assembly rate and mechanism.
  • To determine if the endo-lysosomal system facilitates AβO formation in neurons.
  • To explore the role of AβOs in Tau missorting and neuronal dysfunction.

Main Methods:

  • In vitro kinetic studies of Aβ assembly at varying pH.
  • Neuronal cell culture models.
  • Biochemical and imaging techniques to detect AβOs, Tau pathology, and synaptic function.

Main Results:

  • AβO assembly is accelerated ~8,000-fold at acidic pH, favoring oligomers over fibrils.
  • Acidic pH and high Aβ concentration promote extensive Aβ42 oligomer formation in vitro.
  • Targeting dimeric Aβ variants (dimAβ) to neurons induced AβO formation, Tau missorting, and impaired neuronal activity.

Conclusions:

  • The endosomal/lysosomal system is a critical site for the assembly of pathomechanistically relevant AβOs.
  • pH-dependent AβO formation contributes to Alzheimer's disease pathogenesis.
  • Targeting AβO assembly within endosomes may offer therapeutic strategies.